ORAL MORPHINE IS SAFE IN SYMPTOMATIC PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASES

S. Kronborg-White (Aarhus, Denmark), C. Uggerhøj Andersen (Aarhus, Denmark), O. Hilberg (Vejle, Denmark), E. Bendstrup (Aarhus, Denmark)

Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Session: Treatment and prognosis of idiopathic interstitial pneumonia
Session type: Thematic Poster
Number: 1351
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Kronborg-White (Aarhus, Denmark), C. Uggerhøj Andersen (Aarhus, Denmark), O. Hilberg (Vejle, Denmark), E. Bendstrup (Aarhus, Denmark). ORAL MORPHINE IS SAFE IN SYMPTOMATIC PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASES. 1351

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
ASSOCIATION OF EXERCISE CAPACITY AND ENDOTHELIAL FUNCTION IN PATIENTS WITH FIBROSING INTERSTITIAL LUNG DISEASE
Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease
Year: 2021


CORRELATION BETWEEN LUNG AND JOINT INVOLVEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE: CROSS SECTIONAL STUDY
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018


HEART VARIABILITY IN THE PRESENCE OF PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020

EFFICACY OF IRON REPLETION WITHOUT ERYTHROPOIESIS-STIMULATING AGENT IN PATIENTS WITHCHEMOTHERAPY-INDUCED ANEMIA IN LUNG CANCER
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018


DYNAMICS OF GLUTATION SYSTEM INDICATORS IN CHRONIC LUNG DISEASES ON MODEL INHALED TREATMENT
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020

FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021


PHYSIOLOGICAL EFFECTS OF THREE DIFFERENT VENTILATORY MODES IN PATIENTS WITH OBESITY HYPOVENTILATION SYNDROME UNDER NOCTURNAL NONINVASIVE VENTILATION: A PILOT RANDOMIZED STUDY
Source: International Congress 2017 – Noninvasive ventilation for chronic respiratory failure
Year: 2017

“A RANDOMISED CONTROLLED STUDY ON EFFECT OF ORAL MAGNESIUM SUPPLEMENTS IN CONTROL OF SYMPTOMS OF BRONCHIAL ASTHMA AND LUNG FUNCTION PARAMETERS”
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


UTILITY OF THE HIGH FLOW WITH NASAL CANNULA IN THE DECANULATION OF TRAQUEOTOMIZED PATIENTS DURING AN EPISODE OF ACUTE RESPIRATORY INSUFFICIENCY.
Source: International Congress 2018 – New tools for managing respiratory failure
Year: 2018

INTERSTITIAL LUNG DISEASE ASSOCIATED WITH CONNECTIVE TISSUE DISEASE (CTD-ILD): RETROSPECTIVE MULTICENTRIC STUDY
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020


QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THEIR CAREGIVERS
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020

LONG-TERM FOLLOW-UP OF PATIENTS WITH SYSTEMIC SCLEROSIS AND NORMAL OR BORDERLINE PULMONARY PRESSURES
Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension
Year: 2020


PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH INTERSTITIAL PULMONARY DISEASE
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
Year: 2020


PSYCHOLOGICAL FACTORS PREDICTIVE OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020


EXHALED NITRIC OXIDE MEASUREMENTS IN PATIENTS WITH ACUTE-ONSET INTERSTITIAL LUNG DISEASE
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017


EARLY DIAGNOSIS OF LUNG VENTILATION EVENNESS DISORDERS USING NONINVASIVE IMAGING
Source: Virtual Congress 2021 – Pulmonary neoplasia and related pathologies
Year: 2021

DIFFERENCES OF ANXIETY, DEPRESSION AND FUNCTIONAL CAPACITY BETWEEN PATIENTS WITH CARDIORESPIRATORY FAILURE WITH PARTIAL AND TOTAL  ADHERENCE
Source: Virtual Congress 2020 – Pulmonary function and rehabilitation in non-respiratory disease
Year: 2020


A RESPIRATORY TELEREHABILITATION PROGRAM AS MAINTENANCE  IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018



RELATIONSHIP BETWEEN SIX-MINUTE WALK DISTANCE, PULMONARY FUNCTIONS AND PATIENT CENTERED OUTCOMES IN PATIENTS WITH PULMONARY HYPERTENSION
Source: International Congress 2018 – Pulmonary rehabilitation: exercise training, body composition, physical activity and other aspects
Year: 2018